Lingotto Investment Management LLP grew its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,457,656 shares of the company’s stock after buying an additional 607,800 shares […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, May 29th. Zacks Research analyst R. Department now anticipates that the company will earn $0.56 per share for the quarter, down […]
StockNews.com cut shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a strong-buy rating to a buy rating in a research report released on Monday. A number of other research analysts have also recently weighed in on TEVA. The Goldman Sachs Group boosted their target price on shares of Teva Pharmaceutical Industries from $10.00 […]
Keystone Financial Group trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 46,354 shares of the company’s stock after selling 900 shares during the quarter. Keystone […]